About the Author
Dr. Johannes is an associate professor and director of the James L. Voss Veterinary Teaching Hospital at Colorado State University. His industry experience includes working as the former Medical Director at Aratana Therapeutics, Inc., and coordination of the launch of Palladia, the first FDA-approved veterinary cancer therapeutic, during his time with Pfizer Animal Health (now Zoetis, Inc.). Dr. Johannes’s practice experience includes primary care, specialty care, and academic settings. His areas of research interest include oncology therapeutic development, immunotherapeutics, and effective management of oncology treatment–related side effects.